|
AKTX Akari Therapeutics PLC 1541157 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-14,455,000.00 |
| Balance Sheet |
|
Current Assets
|
$3,589,000.00 |
|
Assets
|
$33,889,000.00 |
|
Current Liabilities
|
$13,415,000.00 |
|
Liabilities
|
$19,509,000.00 |
|
Equity
|
$14,380,000.00 |
|
Shares Out
|
91567009533.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,488,000.00 |
|
Investing Cash Flow
|
$382,000.00 |
| Market Analysis |
Market Cap
|
$732,536,076,264.00 |
|
Price
|
$7.54 |
|
PB
|
0.62 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AKTX documents filed with the SEC.
AKTX Filings
Clear
